3 hours Abbott Laboratories (NYSE:ABT) Price Target Increased to $130.00 by Analysts at Royal Bank of Canada MarketBeat
Royal Bank of Canada increased their price target on shares of Abbott Laboratories from $125.00 to $130.00 and gave the stock an “outperform” rating in a research note on Tuesday.
Abbott Labs (ABT) · Canada · NYSE · Royal Bank of Canada · Science